Search

Your search keyword '"Fouda, Genevieve"' showing total 274 results

Search Constraints

Start Over You searched for: Author "Fouda, Genevieve" Remove constraint Author: "Fouda, Genevieve" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
274 results on '"Fouda, Genevieve"'

Search Results

1. Negative Control Outcome Adjustment in Early-Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants

2. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later

3. Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings

4. Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques

5. Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana.

6. Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques

7. Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus

9. Comparative Analysis of Within-Host Dynamics of Acute Infection and Viral Rebound Dynamics in Postnatally SHIV-Infected ART-Treated Infant Rhesus Macaques

10. Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children Less Than 5 Years of Age

16. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

17. Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection

18. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study

19. A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions.

20. In utero human cytomegalovirus infection expands NK cell-like FcγRIII-expressing CD8+ T cells that mediate antibody-dependent functions

22. Assessing the impact of autologous neutralizing antibodies on viral rebound in postnatally SHIV-infected ART-treated infant rhesus macaques

23. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later

24. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.

25. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later

26. Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses

27. Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation

29. Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure

31. Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life

32. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses

33. Early post-vaccination gene signatures correlate with the magnitude and function of vaccine-induced HIV envelope-specific plasma antibodies in infant rhesus macaques

34. Early Post-Vaccination Gene Signatures Correlate With the Magnitude and Function of Vaccine-Induced HIV Envelope-Specific Plasma Antibodies in Infant Rhesus Macaques

35. Additional file 6 of Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area

36. Additional file 5 of Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area

37. Additional file 1 of Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area

38. Additional file 3 of Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area

39. Additional file 2 of Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area

41. Additional file 4 of Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area

42. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection

43. Vertical HIV-1 transmission in the setting of maternal broad and potent antibody responses

44. Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques

45. Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus

46. Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART

47. Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection

48. Vaccine-induced, high magnitude HIV Env-specific antibodies with Fc-mediated effector functions are insufficient to protect infant rhesus macaques against oral SHIV infection

49. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents

50. Maternal HIV-1 envelope–specific antibody responses and reduced risk of perinatal transmission

Catalog

Books, media, physical & digital resources